Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.24.3
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 21,035,401 $ 4,224 $ 68,798,301 $ 104,718 $ (47,871,842)
Beginning balance, Shares at Dec. 31, 2022   4,224,294      
Stock-based compensation expense 123,273   123,273    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 8,542,942 $ 972 8,541,970    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   971,532      
Other comprehensive income loss 61,104     61,104  
Net Income (Loss) (4,477,778)       (4,477,778)
Ending balance at Mar. 31, 2023 25,284,942 $ 5,196 77,463,544 165,822 (52,349,620)
Ending balance, Shares at Mar. 31, 2023   5,195,826      
Beginning balance at Dec. 31, 2022 21,035,401 $ 4,224 68,798,301 104,718 (47,871,842)
Beginning balance, Shares at Dec. 31, 2022   4,224,294      
Net Income (Loss) (14,850,943)        
Ending balance at Sep. 30, 2023 15,017,883 $ 5,361 77,735,450 (143) (62,722,785)
Ending balance, Shares at Sep. 30, 2023   5,360,326      
Beginning balance at Mar. 31, 2023 25,284,942 $ 5,196 77,463,544 165,822 (52,349,620)
Beginning balance, Shares at Mar. 31, 2023   5,195,826      
Stock-based compensation expense 124,845   124,845    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 95 $ 95      
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   95,000      
Other comprehensive income loss (167,536)     (167,536)  
Net Income (Loss) (5,777,966)       (5,777,966)
Ending balance at Jun. 30, 2023 19,464,380 $ 5,291 77,588,389 (1,714) (58,127,586)
Ending balance, Shares at Jun. 30, 2023   5,290,826      
Stock-based compensation expense 129,781   129,781    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 17,350 $ 70 17,280    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   69,500      
Other comprehensive income loss 1,571     1,571  
Net Income (Loss) (4,595,199)       (4,595,199)
Ending balance at Sep. 30, 2023 15,017,883 $ 5,361 77,735,450 (143) (62,722,785)
Ending balance, Shares at Sep. 30, 2023   5,360,326      
Beginning balance at Dec. 31, 2023 $ 10,977,922 $ 6,186 77,871,584 877 (66,900,725)
Beginning balance, Shares at Dec. 31, 2023 6,186,280 6,186,280      
Stock-based compensation expense $ 53,434   53,434    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 397,607 $ 291 397,316    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   290,564      
Other comprehensive income loss (2,677)     (2,677)  
Net Income (Loss) (4,649,635)       (4,649,635)
Ending balance at Mar. 31, 2024 6,776,651 $ 6,477 78,322,334 (1,800) (71,550,360)
Ending balance, Shares at Mar. 31, 2024   6,476,844      
Beginning balance at Dec. 31, 2023 $ 10,977,922 $ 6,186 77,871,584 877 (66,900,725)
Beginning balance, Shares at Dec. 31, 2023 6,186,280 6,186,280      
Net Income (Loss) $ (15,387,309)        
Ending balance at Sep. 30, 2024 $ (530,591) $ 7,464 81,748,225 1,754 (82,288,034)
Ending balance, Shares at Sep. 30, 2024 7,464,070 7,464,070      
Beginning balance at Mar. 31, 2024 $ 6,776,651 $ 6,477 78,322,334 (1,800) (71,550,360)
Beginning balance, Shares at Mar. 31, 2024   6,476,844      
Stock-based compensation expense 30,697   30,697    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 3,248,133 $ 739 3,247,394    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   739,301      
Other comprehensive income loss 776     776  
Net Income (Loss) (4,959,608)       (4,959,608)
Ending balance at Jun. 30, 2024 5,096,649 $ 7,216 81,600,425 (1,024) (76,509,968)
Ending balance, Shares at Jun. 30, 2024   7,216,145      
Stock-based compensation expense 148,024   148,024    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 24 $ 248 (224)    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   247,925      
Other comprehensive income loss 2,778     2,778  
Net Income (Loss) (5,778,066)       (5,778,066)
Ending balance at Sep. 30, 2024 $ (530,591) $ 7,464 $ 81,748,225 $ 1,754 $ (82,288,034)
Ending balance, Shares at Sep. 30, 2024 7,464,070 7,464,070